NYSE$EHC

Encompass Health Corp · Q2 2022 earnings

Q2 2022 earnings · · Investor relations

Briefing

Encompass Health reported strong demand for inpatient rehabilitation services and affirmed its 2022 guidance.

Encompass Health Corporation reported its results of operations for the second quarter ended June 30, 2022. Second quarter discharge growth was 4.9%, on top of 18.7% discharge growth in the second quarter of 2021.

  • Second quarter discharge growth was 4.9%, on top of 18.7% discharge growth in the second quarter of 2021.
  • Net operating revenues increased by 3.3% compared to Q2 2021.
  • Adjusted earnings per share decreased by 23.9% compared to Q2 2021.
  • The Company is affirming its guidance for its ongoing inpatient rehabilitation business for full-year 2022.

Headline financials

Total Revenue

$1.33B

Previous: $1.29B+3.3%
EPS (adj)

$0.89

Previous: $1.17-23.9%
Discharges

51.9K

Previous: 49.5K+4.9%
Net patient revenue per discharge

$20K

Previous: $19.7K+1.3%
Capital Expenditures

-$230M

Previous: -$213M-8.1%
Free Cash Flow

-$181M

Previous: -$99.4M-82.4%
Net Income

$48.7M

Previous: $113M-57.0%
Operating Income

-$254M

Previous: -$227M-11.8%
Gross Profit

$1.28B

Previous: $1.24B+3.2%
Cash & Equivalents

$187M

Previous: $73.2M+154.8%
Total Assets

$7.08B

Previous: $6.61B+7.1%
Stock-Based Comp

$10.2M

Previous: $12M-15.0%

Revenue & EPS history

Encompass Health · Revenue · Quarterly

$1.33B

Q2 2022+3.3%vs Q2 2021
Beat estimate in 6 of 15 quarters(40%)
ActualEstimate

Forward guidance

The Company is affirming its guidance for its ongoing inpatient rehabilitation business for full-year 2022.

Tailwinds

  • Net operating revenues $4,250 to $4,300 million
  • Adjusted EBITDA $820 to $840 million
  • Adjusted earnings per share from continuing operations attributable to Encompass Health $2.77 to $2.91

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2022

Historical avgQ2 2022

+1.2%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+2.5%

Avg return

30 days after

64%

42 / 66 earnings

Positive

+11.8%

Q1 2025

Best reaction

-9.0%

Q1 2015

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.1%+5.0%+6.0%
Q4 2025+5.9%+13.9%+7.4%
Q3 2025-6.9%-6.8%-7.5%
Q1 2025+11.8%+15.4%+17.2%
Q4 2024+1.3%-0.6%+0.7%
Q3 2024+7.0%+5.8%+10.0%
Q2 2024-8.7%-7.5%+1.0%
Q1 2024+0.3%+1.4%+2.5%
Q4 2023+1.7%+1.9%+5.9%
Q3 2023-1.9%+0.9%+6.7%
Q2 2023+5.0%+6.4%+7.6%
Q1 2023+0.7%-0.6%-5.9%
Q4 2022+1.6%+3.1%-9.1%
Q3 2022+6.4%+11.1%+16.6%
Q2 2022+0.6%+4.5%-4.0%
Q1 2022+2.6%+2.5%-2.0%
Q4 2021+1.5%-2.9%+8.8%
Q3 2021-6.0%-5.8%-9.8%
Q2 2021+0.7%+3.5%-4.1%
Q1 2021-1.6%-2.7%-2.5%
Q4 2020-3.9%-6.2%-6.1%
Q3 2020-2.6%-3.0%+25.9%
Q2 2020+4.5%+3.1%-6.4%
Q1 2020-1.1%-7.1%+6.4%
Q4 2019+0.4%+3.1%-2.6%
Q3 2019-5.8%+2.0%+5.5%
Q2 2019-4.0%-7.4%-12.6%
Q1 2019+5.3%+3.6%-4.6%
Q4 2018-4.4%-3.5%-13.3%
Q3 2018-5.7%-4.0%+1.4%
Q2 2018+8.8%+5.9%+17.4%
Q1 2018+7.2%+7.3%+10.3%
Q4 2017+3.0%+3.9%+7.7%
Q3 2017+1.8%+2.0%+8.7%
Q2 2017+1.9%-0.2%+3.6%
Q1 2017+7.9%+10.0%+6.3%
Q4 2016+0.1%+0.5%-1.9%
Q3 2016+1.8%+0.7%+5.6%
Q2 2016+6.7%+3.1%-0.3%
Q1 2016+10.9%
Q4 2015+9.2%
Q3 2015-0.3%
Q2 2015-2.9%
Q1 2015-9.0%
Q4 2014-4.7%
Q3 2014-3.0%
Q2 2014+7.4%
Q1 2014-0.4%
Q4 2013-2.8%
Q3 2013+0.6%
Q2 2013+4.7%
Q1 2013+3.1%
Q4 2012+7.2%
Q3 2012+2.5%
Q2 2012-3.7%
Q1 2012+9.2%
Q4 2010+3.9%
Q4 2011+3.9%
Q3 2011-1.0%
Q2 2011-9.0%
Q1 2010+0.4%
Q1 2011+2.5%
Q4 2008+7.8%
Q3 2010+2.2%
Q2 2010-1.0%
Q4 2009-1.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro